Artículos por temáticas

Striatal astrocytes produce neuroblasts in an excitotoxic model of Huntington's disease.

Nato G, Caramello A, Trova S, Avataneo V, Rolando C, Taylor V, Buffo A, Peretto P, Luzzati F.

Development. 2015 Mar 1;142(5):840-5. doi: 10.1242/dev.116657.

Mitochondrial modulators in experimental Huntington's disease: reversal of mitochondrial dysfunctions and cognitive deficits.

Mehrotra A, Kanwal A, Banerjee SK, Sandhir R.

Neurobiol Aging. 2015 Jun;36(6):2186-200. doi: 10.1016/j.neurobiolaging.2015.02.004.

Identification of elevated urea as a severe, ubiquitous metabolic defect in the brain of patients with Huntington's disease.

Patassini S, Begley P, Reid SJ, Xu J, Church SJ, Curtis M, Dragunow M, Waldvogel HJ, Unwin RD, Snell RG, Faull RL, Cooper GJ.

Biochem Biophys Res Commun. 2015 Dec 4-11;468(1-2):161-6. doi: 10.1016/j.bbrc.2015.10.140.

Age-, tissue- and length-dependent bidirectional somatic CAG•CTG repeat instability in an allelic series of R6/2 Huntington disease mice.

Larson E, Fyfe I, Morton AJ, Monckton DG.

Neurobiol Dis. 2015 Apr;76:98-111. doi: 10.1016/j.nbd.2015.01.004.

Three Huntington's Disease Specific Mutation-Carrying Human Embryonic Stem Cell Lines Have Stable Number of CAG Repeats upon In Vitro Differentiation into Cardiomyocytes.

Jacquet L, Neueder A, Földes G, Karagiannis P, Hobbs C, Jolinon N, Mioulane M, Sakai T, Harding SE, Ilic D.

PLoS One. 2015 May 20;10(5):e0126860. doi: 10.1371/journal.pone.0126860.

Childhood-onset (Juvenile) Huntington's disease: A rare case report.

Patra KC, Shirolkar MS.

J Pediatr Neurosci. 2015 Jul-Sep;10(3):276-9. doi: 10.4103/1817-1745.165709.

Interaction without intent: the shape of the social world in Huntington's disease.

Eddy CM, Rickards HE.

Soc Cogn Affect Neurosci. 2015 Sep;10(9):1228-35. doi: 10.1093/scan/nsv012.

Longitudinal change in white matter microstructure in Huntington's disease: The IMAGE-HD study.

Poudel GR, Stout JC, Domínguez D JF, Churchyard A, Chua P, Egan GF, Georgiou-Karistianis N.

Neurobiol Dis. 2015 Feb;74:406-12. doi: 10.1016/j.nbd.2014.12.009.

Relationship satisfaction and sexuality in Huntington's disease.

Reininghaus E, Lackner N.

Handb Clin Neurol. 2015;130:325-34. doi: 10.1016/B978-0-444-63247-0.00018-3. Review.

Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice.

Valenza M, Chen JY, Di Paolo E, Ruozi B, Belletti D, Ferrari Bardile C, Leoni V, Caccia C, Brilli E, Di Donato S, Boido MM, Vercelli A, Vandelli MA, Forni F, Cepeda C, Levine MS, Tosi G, Cattaneo E.

EMBO Mol Med. 2015 Nov 20;7(12):1547-64. doi: 10.15252/emmm.201505413.

Development of a series of aryl pyrimidine kynurenine monooxygenase inhibitors as potential therapeutic agents for the treatment of Huntington's disease.

Toledo-Sherman LM, Prime ME, Mrzljak L, Beconi MG, Beresford A, Brookfield FA, Brown CJ, Cardaun I, Courtney SM, Dijkman U, Hamelin-Flegg E, Johnson PD, Kempf V, Lyons K, Matthews K, Mitchell WL, O'Co

J Med Chem. 2015 Feb 12;58(3):1159-83. doi: 10.1021/jm501350y.

Putting the Brakes on Huntington Disease in a Mouse Experimental Model.

Kim JC, Mirkin SM.

PLoS Genet. 2015 Aug 6;11(8):e1005409. doi: 10.1371/journal.pgen.1005409. No abstract available.

Neural Compensation in Huntington's Disease: Teaching Mental Disorders New Tricks?

Wolf RC, Sambataro F.

EBioMedicine. 2015 Oct 9;2(10):1288-9. doi: 10.1016/j.ebiom.2015.10.005. No abstract available.

PINK1-induced mitophagy promotes neuroprotection in Huntington's disease.

Khalil B, El Fissi N, Aouane A, Cabirol-Pol MJ, Rival T, Liévens JC.

Cell Death Dis. 2015 Jan 22;6:e1617. doi: 10.1038/cddis.2014.581.

Adult neural progenitor cells from Huntington's disease mouse brain exhibit increased proliferation and migration due to enhanced calcium and ROS signals.

Xie W, Wang JQ, Wang QC, Wang Y, Yao S, Tang TS.

Cell Prolif. 2015 Oct;48(5):517-31. doi: 10.1111/cpr.12205.